1,058 results on '"Yoshida, Soichiro"'
Search Results
2. Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study
3. A diagnostic approach of various urethral diseases using multimodal imaging findings: comprehensive overview
4. Prognostic Impact and Genomic Backgrounds of Renal Parenchymal Infiltration or Micronodular Spread in Nonmetastatic Clear Cell Renal Cell Carcinoma
5. Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer
6. A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
7. Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients
8. Prostate and metastasis diffusion volume based on apparent diffusion coefficient as a prognostic factor in Hormone-naïve prostate Cancer
9. Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma
10. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation
11. Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration
12. Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases.
13. Location‐specific diagnostic efficiency of photodynamic diagnosis‐guided biopsy in bladder mapping biopsies.
14. A case of double‐negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab.
15. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements
16. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer
17. PD19-09 ARE THERE DIFFERENCES IN MRI FINDINGS BETWEEN CRIBRIFORM AND NON-CRIBRIFORM CANCER? AN ANALYSIS USING RADIOMICS AND DELTA-RADIOMICS
18. PD38-04 EXPLORING THE ROLE OF FDG PET/CT IN PREDICTING PEMBROLIZUMAB RESPONSE FOR METASTATIC UROTHELIAL CARCINOMA
19. MP53-06 GUSTAVE ROUSSY IMMUNE SCORE PREDICTS SURVIVAL OUTCOME OF PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA TREATED WITH PEMBROLIZUMAB: A MULTICENTER STUDY OF 321 PATIENTS (YUSHIMA STUDY)
20. MP49-05 RISK OF POST-BIOPSY PROSTATITIS AMONG PATIENTS UNDERGOING TRANSRECTAL AND TRANSPERINEAL MRI/US FUSION PROSTATE BIOPSY
21. PD30-02 DIAGNOSTIC PERFORMANCE OF FLUORESCENCE CYSTOSCOPY USING ORAL 5-AMINOLEVULINIC ACID IN TRANSURETHRAL RESECTION OF BLADDER TUMOR AFTER BCG TREATMENT
22. MP71-03 CAN PHOTODYNAMIC DIAGNOSIS-GUIDED BIOPSY REPLACE BLADDER MAPPING BIOPSY?
23. MP30-08 DELTA-RADIOMICS ANALYSIS IN COMPARISON TO RADIOMICS ANALYSIS USING DYNAMIC COMPUTED TOMOGRAPHY FOR PREOPERATIVE RISK STRATIFICATION IN UPPER URINARY TRACT UROTHELIAL CARCINOMA
24. MP77-20 DIAGNOSTIC ACCURACY OF FLUORESCENCE CYSTOSCOPY USING ORAL 5-AMINOLEVULINIC ACID IN TRANSURETHRAL RESECTION OF BLADDER TUMOR AFTER CHEMORADIATION THERAPY FOR MUSCLE INVASIVE BLADDER CANCER
25. PD34-07 LONG-TERM ONCOLOGIC OUTCOMES OF TETRAMODAL BLADDER-PRESERVATION THERAPY INCORPORATING INDUCTION CHEMORADIOTHERAPY AND CONSOLIDATIVE PARTIAL CYSTECTOMY WITH PELVIC LYMPHNODE DISSECTION FOR MUSCLE-INVASIVE BLADDER CANCER
26. MP44-09 PROGNOSTIC NOMOGRAMS INCORPORATING PREOPERATIVE CRP LEVEL FOR PREDICTING SURVIVAL OUTCOMES IN PATIENTS WITH NONMETASTATIC CLEAR CELL RENAL CELL CARCINOMA: INMARC STUDY
27. Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma
28. Human kidney-derived tubular organoid, tubuloid, recapitulates cellular senescence, inflammation and fibrosis by repeated-cisplatin treatment
29. Utility of positive core number on MRI‐ultrasound fusion targeted biopsy in combination with PI‐RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer
30. Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity
31. Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer
32. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review
33. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non–muscle-invasive Bladder Cancer
34. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy
35. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab
36. Stepwise algorithm using computed tomography and magnetic resonance imaging for differential diagnosis of fat‐poor angiomyolipoma in small renal masses: A prospective validation study.
37. Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications
38. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer
39. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy
40. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report
41. Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients
42. Prolonged hypoglycemia after the resection of pheochromocytoma in a hemodialysis patient.
43. Computer-aided diagnosis with a convolutional neural network algorithm for automated detection of urinary tract stones on plain X-ray
44. Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor
45. Dependency of mesh size and loading history on crack propagation energy of cyclic ductile fracture model
46. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma
47. Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiation Therapy
48. Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients.
49. Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5‐aminolevulinic acid.
50. Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5‐aminolevulinic acid
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.